NCT05407428
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Sourasky medical center Tel Aviv, Israel
Clinical trial condition
TDP-43 Proteinopathies
Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.
871 public trials
211 recruiting studies
TDP-43 Proteinopathies trial results
NCT03579017
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Cognition Disorders, +13 more
- Locations
-
- Haukeland University Hospital Bergen, Norway
Completed
Communication Bridge 2
NCT03371706
- Conditions
- Alzheimer Disease, Aphasia, Aphasia, Primary Progressive, +24 more
- Locations
-
- The Healthy Aging & Alzheimer's Research Care Center (University of Chicago) Chicago, Illinois, United States
NCT06206629
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Hôpital neurologique Pierre Wertheimer Bron, Rhone, France
- CHU de Nantes Nantes, France
NCT02714036
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- South Shore Neurologic Associates, P.C. Patchogue, New York, United States
NCT06608719
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Hitonowa Medical Chiyoda City, Tokyo, Japan
Completed
Quality of Life Evaluation with the SRI Questionnaire of ALS Patient with Non-invasive Ventilation
NCT05498883
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Pneumology departement, Pitié-Salpêtrière hospital, GHU APHP-Sorbonne Université Paris, France
NCT03030586
- Conditions
- Alzheimer Disease, Alzheimer Disease (AD), Basal Ganglia Diseases, +31 more
- Locations
-
- Cliniques Universitaires Saint-Luc Brussels, Belgium
- ERASME Hospital Brussels, Belgium
- Hopitaux Universitaires de Strasbourg Strasbourg, Alsace, France
- Centre Hospitalier Universitaire de Besançon Besançon, France
Completed
Rapamycin Treatment for ALS
NCT03359538
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Centro Sla, Irccs A.O.U. S.Martino Ist, Genova Genova, Italy
- Centro Clinico Nemo, Fondazione Serena Onlus, Milano Milan, Italy
- Centro Sla, Irccs Istituto Carlo Besta, Milano Milan, Italy
- Centro Sla, Ospedale Civile S. Agostino Estense, A.O.U. Modena Modena, Italy
NCT05006352
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- HonorHealth Scottsdale, Arizona, United States
- University of California at San Diego San Diego, California, United States
- California Pacific Medical Center San Francisco, California, United States
- PPD Orlando Orlando, Florida, United States